|
 |
| home > pmps > spring 2004 > planning and optimisation software facilitates production planning of ingredients |
|
|
 PUBLICATIONS |
Pharmaceutical Manufacturing and Packing Sourcer
|
Planning in the pharmaceutical industry is in a class of its own. Joint products, GMP guidelines, campaign and batch production make life difficult for the planner. Rough planning usually exists in many plants. This process, however, is quickly frustrated by everyday problems. A new mathematical approach seeks to eliminate the need to make inaccurate delivery promises. Not only does it radically improve delivery reliability but, for the first time, it also allows tactical and strategic decisions.
Drug production requires special care, and many regulations must be observed. Process details and good manufacturing practice (GMP) guidelines have to be strictly adhered to. In addition to documented manufacturing specifications and the ability to trace batches, an ingredient company also has to deal with the fact that specific preparations cannot be manufactured in sequence. Moreover, the production of substances is carried out in multiple steps - between 15 and 20. Flexibility is required in such plants and multipurpose equipment is standard. Between 30 and 35 units as, for example special equipment, agitators, filters, dryers or cleaning units, are connected in various ways - an advantage for production, which can rapidly respond to requests. |
Read full article >>
|
|
 |
|
| Rate this article |
You must be a member of the site to make a vote. |
|
Average rating: |
0 |
| | | | | |
|
|
 |
Industry Events |
 |
4th Annual Patient Recruitment and Retention in Clinical Trials
13-15 October 2008, Amsterdam
Patient recruitment
is now consuming thirty percent of clinical trial time - more time than any
other clinical trial activity - and almost half of all trial delays result from
patient recruitment problems.
As the
recruiting culture becomes more sophisticated and the forces affecting patient
enrollment grow more numerous and complex, pharmaceutical companies are
striving to discover new strategies to facilitate enrollment in clinical
trials.
With
increasing industry pressure to develop, test and market greater numbers of new
drugs faster, pharmaceutical companies need to perform clinical trials as
quickly as possible. Inefficient patient recruitment processes is a formidable
barrier to pharmaceutical companies' success in launching new products.
Improving the patient recruitment process is imperative to avoid wasted
investments and eliminate costly delays in bringing new drugs to market --
today and even more so in the not-so-distant future. Improved patient
recruitment presents one of the largest opportunities for pharmaceutical
companies to eliminate delays in clinical trials, thereby making it possible to
reduce time to market. With patent time limits and large overheads
meaning that any delays in the development timeline can be disastrous, a good
understanding of how to successfully recruit patients for trials is vital for
any company looking to succeed.
More info >> |
|
 |
News and Press Releases |
 |
Biovian expands - and invests in new capacity
More info >> |
|
 |
